Publications

Detailed Information

EFFECTS OF PEMBROLIZUMAB ON THE TUMOR MICROENVIRONMENT (TME) AFTER ONE PRESURGERY TREATMENT CYCLE IN PATIENTS WITH TRIPLE-NEGATIVE BREAST CANCER (TNBC): PHASE 1B KEYNOTE-173 STUDY

Cited 1 time in Web of Science Cited 0 time in Scopus
Authors

Schmid, Peter; Park, Yeon Hee; Munoz-Couselo, Eva; Kim, Sung-Bae; Sohn, Joohyuk; Im, Seock-Ah; Holgado, Esther; Foukakis, Theodoros; Kuemmel, Sherko; Dent, Rebecca; Sun, Yuan; Huang, Lingkang; Yearley, Jennifer; Jelinic, Petar; Karantza, Vassiliki; Cortes, Javier

Issue Date
2021-11
Publisher
BioMed Central
Citation
Journal for ImmunoTherapy of Cancer, Vol.9, pp.A364-A364
ISSN
2051-1426
URI
https://hdl.handle.net/10371/199002
DOI
https://doi.org/10.1136/jitc-2021-SITC2021.338
Files in This Item:
There are no files associated with this item.
Appears in Collections:

Related Researcher

  • College of Medicine
  • Department of Medicine
Research Area Clinical Medicine

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share